Physician profile
Yang Li
NPI 1508328444
$1,311.43
in general payments reported to CMS, 2019-2025
15 companies · $531 in 2025
The $531 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $780 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,311.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $233.70 | 2024-2025 | |
| Convatec INC. | $167.75 | 2025 | |
| Incyte Corporation | $144.03 | 2025 | Opzelura |
| Abbvie INC. | $131.43 | 2024 | |
| Arcutis Biotherapeutics, INC. | $117.15 | 2024 | Zoryve |
| Kyowa Kirin, INC. | $106.80 | 2024 | Poteligeo |
| E.R. Squibb & Sons, L.L.C. | $99.13 | 2024 | Sotyktu |
| Ucb, INC. | $71.63 | 2024-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $57.72 | 2024 | Libtayo |
| Sun Pharmaceutical Industries INC. | $47.93 | 2025 | |
| Lilly USA, LLC | $45.44 | 2025 | Ebglyss |
| Amgen INC. | $28.33 | 2025 | Otezla |
| Janssen Biotech, INC. | $26.64 | 2024 | Tremfya |
| Organon LLC | $18.94 | 2025 | Vtama |
| Verrica Pharmaceuticals INC. | $14.81 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yang Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.